Page last updated: 2024-11-05

triazolam and Recrudescence

triazolam has been researched along with Recrudescence in 7 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Research Excerpts

ExcerptRelevanceReference
"Within a double-blind, comparative study on the effects of the long-half-life benzodiazepine (BDZ), quazepam, and the short-half-life BDZ, triazolam, on clinical symptomatology, sleep and anxiety of 45 patients with insomnia based on a mild to moderate generalized anxiety disorder (GAD) (ICD-9 code: 307."9.07Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam). ( Anderer, P; Brandstätter, N; Frey, R; Grünberger, J; Klösch, G; Mandl, M; Saletu, B; Wetter, T; Zeitlhofer, J, 1994)
"Within a double-blind, comparative study on the effects of the long-half-life benzodiazepine (BDZ), quazepam, and the short-half-life BDZ, triazolam, on clinical symptomatology, sleep and anxiety of 45 patients with insomnia based on a mild to moderate generalized anxiety disorder (GAD) (ICD-9 code: 307."5.07Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam). ( Anderer, P; Brandstätter, N; Frey, R; Grünberger, J; Klösch, G; Mandl, M; Saletu, B; Wetter, T; Zeitlhofer, J, 1994)
"Sixty-five patients, affected by sleep disorders, were entered into the study."2.67Quazepam versus triazolam in patients with sleep disorders: a double-blind study. ( Altamura, AC; Gianetti, S; Mauri, MC; Pugnetti, L, 1993)
"Stupor is a diagnostic challenge at emergency department."1.48Segmental Hair Testing of Triazolam to Unmask a Suspected Case of Idiopathic Recurrent Stupor. ( Antelmi, E; Busardò, FP; Moresco, M; Pichini, S; Pizza, F; Plazzi, G; Postiglione, E, 2018)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's4 (57.14)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Postiglione, E1
Antelmi, E1
Moresco, M1
Pichini, S1
Pizza, F1
Plazzi, G1
Busardò, FP1
Mitchell, AR1
Mauri, MC1
Gianetti, S1
Pugnetti, L1
Altamura, AC1
Saletu, B1
Anderer, P1
Brandstätter, N1
Frey, R1
Grünberger, J1
Klösch, G1
Mandl, M1
Wetter, T1
Zeitlhofer, J1
Hajak, G1
Clarenbach, P1
Fischer, W1
Rodenbeck, A1
Bandelow, B1
Broocks, A1
Rüther, E1
Torr, SR1
Haskel, EJ1
VonVoigtlander, PF1
Bergmann, SR1
Abendschein, DR1
Laplane, D1
Baulac, M1
Lacomblez, L1

Trials

3 trials available for triazolam and Recrudescence

ArticleYear
Quazepam versus triazolam in patients with sleep disorders: a double-blind study.
    International journal of clinical pharmacology research, 1993, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Double-Blind Method; Female; Human

1993
Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Neuropsychobiology, 1994, Volume: 29, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Double-Blind Method; Female; Humans; Hypnotics

1994
Rebound insomnia after hypnotic withdrawal in insomniac outpatients.
    European archives of psychiatry and clinical neuroscience, 1998, Volume: 248, Issue:3

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Anti-Anxiety Agents; Azabicyclo Compounds; Double-Bli

1998

Other Studies

4 other studies available for triazolam and Recrudescence

ArticleYear
Segmental Hair Testing of Triazolam to Unmask a Suspected Case of Idiopathic Recurrent Stupor.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018, 04-15, Volume: 14, Issue:4

    Topics: Adult; Hair; Humans; Male; Recurrence; Stupor; Substance-Related Disorders; Time Factors; Triazolam

2018
A placebo-controlled, crossover comparison of oral triazolam prior to sham patient-activated shock delivery during sinus rhythm in a group of patients with recurrent atrial fibrillation.
    Journal of cardiovascular electrophysiology, 2006, Volume: 17, Issue:9

    Topics: Atrial Fibrillation; Controlled Clinical Trials as Topic; Cross-Over Studies; Electric Countershock;

2006
Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor.
    Journal of the American College of Cardiology, 1991, Volume: 18, Issue:7

    Topics: Administration, Oral; Animals; Benzodiazepines; Bleeding Time; Blood Coagulation; Blood Flow Velocit

1991
[Convulsions 12 hours after the ingestion of benzodiazepine with a short half-life].
    Presse medicale (Paris, France : 1983), 1988, Mar-12, Volume: 17, Issue:9

    Topics: Adult; Female; Half-Life; Humans; Recurrence; Seizures; Time Factors; Triazolam

1988